These findings were recently replicated in vivo in a mouse model of triple-negative BC revealing that re-expression of IRF5 in 4T1 cells that lack endogenous IRF5 led to an increased number of tumor infiltrating leukocytes with anti-tumorigenic function, reduced metastasis, and increased overall survival3. This evidence concerns the gene IRF5 and neoplasm.